[go: up one dir, main page]

PE20050524A1 - Derivados de acido fenoxiacetico - Google Patents

Derivados de acido fenoxiacetico

Info

Publication number
PE20050524A1
PE20050524A1 PE2004000459A PE2004000459A PE20050524A1 PE 20050524 A1 PE20050524 A1 PE 20050524A1 PE 2004000459 A PE2004000459 A PE 2004000459A PE 2004000459 A PE2004000459 A PE 2004000459A PE 20050524 A1 PE20050524 A1 PE 20050524A1
Authority
PE
Peru
Prior art keywords
alkyl
derivatives
amino
ethyl
halogen
Prior art date
Application number
PE2004000459A
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050524(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE20050524A1 publication Critical patent/PE20050524A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE AL USO DE DERIVADOS DEL ACIDO FENOXIACETICO DE FORMULA (I), EN DONDE X E Y ES UN CARBONO QUIRAL R O S DE CONFIGUARACION OPUESTA, R1 ES O, ALCOXI(C1-C6), ARILALCOXI(C1-C6), AMINO PRIMARIO, O MONO O DI (ALQUIL(C1-C6)AMINO); R2 Y R3 UNO ES H Y EL OTRO H, HALOGENO, ALQUILO(C1-C6), F3CH3-, O ALCOXI(C1-C6); R4 ES HALOGENO, ALQUILO(C1-C6), ENTRE OTROS, EN LA PREPARACION DE MEDICAMENTOS DE ADMINISTRACION ORAL, POR VIA INTRAVENOSA O TRANSDERMICA O COMO SUPOSITORIO. UN COMPUESTO PREFERIDO ES: 2-[4-(2-{[(1S,2R)-2-HIDROXI-2-(4-HIDROXIFENIL)-1-METIL-ETIL]AMINO}ETIL)-2,5-DIMETILFENOXI] ACETATO DE (-)- ETILO, O LA FORMA DE CLORHIDRATO O DE ACIDO ACETICO, SIENDO ESTOS COMPUESTOS UTILES EN EL TRATAMINETO DE VEJIGA HIPERACTIVA (VEJIGA SOBREACTIVA "OAB") YA SEA DE ORIGEN NEUROGENICO O IDIOPATICO
PE2004000459A 2003-05-05 2004-05-05 Derivados de acido fenoxiacetico PE20050524A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase

Publications (1)

Publication Number Publication Date
PE20050524A1 true PE20050524A1 (es) 2005-07-07

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000459A PE20050524A1 (es) 2003-05-05 2004-05-05 Derivados de acido fenoxiacetico

Country Status (26)

Country Link
US (1) US20040229947A1 (es)
EP (1) EP1620085B1 (es)
JP (1) JP4602969B2 (es)
KR (1) KR101052804B1 (es)
AR (1) AR044169A1 (es)
AT (1) ATE401878T1 (es)
AU (1) AU2004236596B2 (es)
BR (1) BRPI0409980A (es)
CA (1) CA2524023C (es)
CL (1) CL2004000952A1 (es)
CY (1) CY1108425T1 (es)
DE (1) DE602004015272D1 (es)
DK (1) DK1620085T3 (es)
ES (1) ES2309513T3 (es)
IL (1) IL171713A (es)
MX (1) MXPA05011862A (es)
MY (1) MY141756A (es)
NZ (1) NZ543347A (es)
PE (1) PE20050524A1 (es)
PL (1) PL1620085T3 (es)
PT (1) PT1620085E (es)
RU (1) RU2342133C2 (es)
SI (1) SI1620085T1 (es)
TW (1) TWI351279B (es)
UY (1) UY28306A1 (es)
WO (1) WO2004098586A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
JPWO2006118087A1 (ja) * 2005-04-26 2008-12-18 キッセイ薬品工業株式会社 ヒドロキシノルエフェドリン誘導体塩酸塩・１／４水和物の結晶
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
CN110869022A (zh) 2017-06-06 2020-03-06 乌洛万特科学有限公司 使用维贝隆以治疗膀胱过度活动症

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60041110D1 (de) * 1999-11-01 2009-01-29 Sumitomo Chemical Co 6-Hydroxy-5,6-dihydrouracile als Herbizide
EA006022B1 (ru) * 2001-09-13 2005-08-25 Киссеи Фармасьютикал Ко., Лтд. Кристаллы производных гидроксинорэфедрина

Also Published As

Publication number Publication date
AU2004236596A1 (en) 2004-11-18
AU2004236596B2 (en) 2010-03-11
EP1620085A1 (en) 2006-02-01
TWI351279B (en) 2011-11-01
DE602004015272D1 (de) 2008-09-04
KR101052804B1 (ko) 2011-07-29
PT1620085E (pt) 2008-08-07
CA2524023C (en) 2011-11-22
IL171713A (en) 2011-12-29
MXPA05011862A (es) 2006-02-17
AR044169A1 (es) 2005-08-24
MY141756A (en) 2010-06-30
TW200509902A (en) 2005-03-16
JP4602969B2 (ja) 2010-12-22
CL2004000952A1 (es) 2005-03-04
NZ543347A (en) 2008-05-30
SI1620085T1 (sl) 2008-12-31
JP2006525318A (ja) 2006-11-09
ATE401878T1 (de) 2008-08-15
CA2524023A1 (en) 2004-11-18
RU2342133C2 (ru) 2008-12-27
PL1620085T3 (pl) 2009-01-30
DK1620085T3 (da) 2008-11-24
UY28306A1 (es) 2004-12-31
US20040229947A1 (en) 2004-11-18
BRPI0409980A (pt) 2006-05-09
KR20060009886A (ko) 2006-02-01
CY1108425T1 (el) 2014-04-09
RU2005137701A (ru) 2006-06-10
ES2309513T3 (es) 2008-12-16
WO2004098586A1 (en) 2004-11-18
EP1620085B1 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
PE20060921A1 (es) Procedimiento para preparar 8-(3-amino-piperidin-1-il)-xantinas quirales
CO6460743A2 (es) Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica
AR055060A1 (es) Derivados de n-(piridin-2-il)-sulfonamida
HRP20090387T1 (hr) Postupak reduciranja alfa, beta nezasićenih ketona u opioidnim sastavima
ME01294B (me) Nova jedinjenja i kompozicije i metode upotrebe
MY148566A (en) Crystalline solvates and complexes of (is) -1, 5- anhydro-1 -c-(3-( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes
CO6400139A2 (es) Derivados de ciclopenta[c]pirool-2-carboxilatos, su preparación y su aplicación en terapéutica
PE20120620A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
AR049291A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
PE20060680A1 (es) Compuestos de morfolina sustituida como inhibidores de la recaptacion de norepinefrina
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
RU2010128940A (ru) Производные бензилфенилциклогексана и способы их применения
RU2009145270A (ru) Производные 1, 3-дигидроимидазол-2-тиона в качестве ингибиторов дофамин-бета-гидроксилазы
PE20060589A1 (es) FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
GEP20125548B (en) New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
MA27197A1 (fr) Sels de tolterodine
NO20080816L (no) Anvendelse av delmopinol ved behandling av kviser
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
ECSP088257A (es) Derivados de amida
PE20050524A1 (es) Derivados de acido fenoxiacetico
AR054102A1 (es) Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas
BR0215873A (pt) Composto, composição farmacêutica, método de inibição de desenvolvimento de células microbianas, método para o tratamento de condições microbianas em mamìferos e processo para a preparação de um composto
AR071538A1 (es) Derivados de macrolactona

Legal Events

Date Code Title Description
FC Refusal